GB9017351D0 - Medicaments for treatment of atherosclerosis - Google Patents

Medicaments for treatment of atherosclerosis

Info

Publication number
GB9017351D0
GB9017351D0 GB909017351A GB9017351A GB9017351D0 GB 9017351 D0 GB9017351 D0 GB 9017351D0 GB 909017351 A GB909017351 A GB 909017351A GB 9017351 A GB9017351 A GB 9017351A GB 9017351 D0 GB9017351 D0 GB 9017351D0
Authority
GB
United Kingdom
Prior art keywords
atherosclerosis
medicaments
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909017351A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Priority to GB909017351A priority Critical patent/GB9017351D0/en
Publication of GB9017351D0 publication Critical patent/GB9017351D0/en
Priority to JP3513228A priority patent/JPH06500537A/en
Priority to EP91914214A priority patent/EP0543855A1/en
Priority to PCT/GB1991/001320 priority patent/WO1992003130A1/en
Priority to US08/325,941 priority patent/US5461072A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB909017351A 1990-08-02 1990-08-08 Medicaments for treatment of atherosclerosis Pending GB9017351D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB909017351A GB9017351D0 (en) 1990-08-08 1990-08-08 Medicaments for treatment of atherosclerosis
JP3513228A JPH06500537A (en) 1990-08-08 1991-08-02 Use of arylhydroxyurea compounds for the treatment of atherosclerosis
EP91914214A EP0543855A1 (en) 1990-08-08 1991-08-02 Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
PCT/GB1991/001320 WO1992003130A1 (en) 1990-08-08 1991-08-02 Use of aryl hydroxyurea compounds for the treatment of atherosclerosis
US08/325,941 US5461072A (en) 1990-08-02 1994-10-17 Use of aryl hydroxyurea compounds for the treatment of atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017351A GB9017351D0 (en) 1990-08-08 1990-08-08 Medicaments for treatment of atherosclerosis

Publications (1)

Publication Number Publication Date
GB9017351D0 true GB9017351D0 (en) 1990-09-19

Family

ID=10680330

Family Applications (1)

Application Number Title Priority Date Filing Date
GB909017351A Pending GB9017351D0 (en) 1990-08-02 1990-08-08 Medicaments for treatment of atherosclerosis

Country Status (4)

Country Link
EP (1) EP0543855A1 (en)
JP (1) JPH06500537A (en)
GB (1) GB9017351D0 (en)
WO (1) WO1992003130A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350761A (en) * 1991-07-30 1994-09-27 Ciba-Geigy Corporation Indolyl substituted hydroxylamine derivatives
US5334600A (en) * 1991-07-30 1994-08-02 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
US5260316A (en) * 1991-07-30 1993-11-09 Ciba-Geigy Corporation Isoquinolyl substituted hydroxylamine derivatives
WO1994026269A1 (en) * 1993-05-10 1994-11-24 Sepracor, Inc. Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
US5459154A (en) * 1993-11-08 1995-10-17 American Home Products Corporation N-hydroxyureas as 5-lipoxygenase inhibitors and inhibitors of oxidative modification of low density lipoprotein
US5468760A (en) * 1993-11-08 1995-11-21 American Home Products Corporation Aralkyl-N-hydroxyureas as inhibitors of 5-lipoxygenase and oxidation of low density lipoprotein
US5428048A (en) * 1993-11-08 1995-06-27 American Home Products Corporation Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
CN100427609C (en) 2001-10-24 2008-10-22 加利福尼亚大学董事会 Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis
PL371251A1 (en) 2002-01-11 2005-06-13 Biorex Kutato Es Fejlesztö Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59210021A (en) * 1983-05-12 1984-11-28 Kyowa Hakko Kogyo Co Ltd Preventing and treating agent for disease caused by lipoxygenase metabolite
DE3443308A1 (en) * 1984-11-28 1986-05-28 Bayer Ag, 5090 Leverkusen 1-HETEROARYL-4-ARYL-PYRAZOLIN-5-ONE FOR USE AS A MEDICINAL PRODUCT
DE3882732T2 (en) * 1987-02-10 1993-12-02 Abbott Lab Indole, benzofuran, benzothiophene-containing lipoxygenase inhibiting compounds.

Also Published As

Publication number Publication date
JPH06500537A (en) 1994-01-20
WO1992003130A1 (en) 1992-03-05
EP0543855A1 (en) 1993-06-02

Similar Documents

Publication Publication Date Title
AP9100339A0 (en) Medicaments
EP0460912A3 (en) Medicaments for the treatment of sexual disorder
AU8000291A (en) Imidazoles for the treatment of atherosclerosis
GB9022175D0 (en) Treatment of fibres
GB9027968D0 (en) Method of treatment
GB9017351D0 (en) Medicaments for treatment of atherosclerosis
GB9015051D0 (en) Pharmaceutical treatment
GB9103278D0 (en) Drug for the treatment of dermatitis
GB9000459D0 (en) Medicaments for treatment of airborne allergies
GB9022470D0 (en) Treatment of clays
GB2243602B (en) Treatment process
GB2241958B (en) Treatment process
GB9021960D0 (en) Treatment of flax
RU1833739C (en) Way of treatment hyperekaliemia
ZA899241B (en) Imidazoles for the treatment of atherosclerosis
PL286564A1 (en) Method of treatment of extragrade pantaerythrite
GB9026564D0 (en) Method of treatment
GB9016831D0 (en) Method of treatment
GB9014959D0 (en) Method of treatment
GB9001031D0 (en) Method of treatment
GB9001029D0 (en) Method of treatment
GB9001028D0 (en) Method of treatment
RU1833722C (en) Method for treatment of sindactyllia
GB2240790B (en) Treatment of wool
GB2242424B (en) Treatment process